Invesco’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-169,052
Closed -$20.5M 4021
2023
Q1
$20.5M Hold
169,052
0.01% 1338
2022
Q4
$19.4M Hold
169,052
0.01% 1391
2022
Q3
$17.1M Buy
169,052
+20,000
+13% +$2.12M 0.01% 1423
2022
Q2
$15.1M Buy
149,052
+27,000
+22% +$2.94M ﹤0.01% 1547
2022
Q1
$14.2M Hold
122,052
﹤0.01% 1731
2021
Q4
$14M Buy
+122,052
New +$13.9M ﹤0.01% 1788
2020
Q4
Sell
-156,700
Closed -$17.5M 3846
2020
Q3
$17.5M Buy
156,700
+23,000
+17% +$2.58M 0.01% 1373
2020
Q2
$14M Buy
+133,700
New +$14.3M 0.01% 1453

Other funds holding BSX.PRA

Invesco's BSX.PRA Position: Q2 2023 in Review

Invesco sold out of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) in Q2 2023, closing a stake of 169,052 shares — an estimated $20.5M sold.

Invesco first reported a position in BSX.PRA in Q2 2020 and held it in 8 quarters. The position peaked at $20.5M in Q1 2023. 1 fund tracked by Wall St. Rank holds BSX.PRA as of Q2 2023.

  • Invesco reported no remaining Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position as of Q2 2023 after selling out during the quarter.
  • Invesco sold 169,052 Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A shares in Q2 2023, an estimated $20.5M.
  • Invesco first reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q2 2020 and held it in 8 quarters.
  • Invesco's Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position peaked at $20.5M in Q1 2023.
  • 1 fund tracked by Wall St. Rank held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A as of Q2 2023.

Based on Invesco's 13F filing for Q2 2023, filed 11 Aug 2023.